Under construction – not a live service
Sign in
Taking people in NetherlandsNo phase

Tests stent placement in the aorta and iliac arteries for blood pressure

Tests stent placement in people with blockages in the aorta and iliac arteries.

Plain-language title generated from the registry record
Registry title: Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

Key facts

Where
Arnhem, NetherlandsSee the site

Where in Netherlands

  • RijnstateArnhem, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Rijnstate Hospital
Trial code
NCT07070583
Record updated
3 April 2026
Original description
Hypertension is a major risk factor for a variety of cardiovascular diseases. When hypertension results from increased vascular resistance due to a narrowing of the descending aorta, it can be effectively treated with stenting. More recently, evidence suggest that stenting in more distal parts of the arterial vascular bed is also associated with a reduction in blood pressure. The investigators hypothesize that stenting of occlusions more distal of the descending aorta decreases the central blood pressure and afterload as reflected by NT-proBNP (N-terminal pro-Brain Natriuretic Peptide), a biomarker of intracardiac pressures and predictor of heart failure events. The goal of this pilot study is to prospectively investigate changes in blood pressure after stent placement in the aorto-iliac region.Read full original descriptionShow less

Impact of Endovascular Treatment of Aorto-iliac Disease on Systemic Hypertension A Pilot Study Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure

Hypertension is a major risk factor for a variety of cardiovascular diseases. When hypertension results from increased vascular resistance due to a narrowing of the descending aorta, it can be effectively treated with stenting. More recently, evidence suggest that stenting in more distal parts of the arterial vascular bed is also associated with a reduction in blood pressure. The investigators hypothesize that stenting of occlusions more distal of the descending aorta decreases the central blood pressure and afterload as reflected by NT-proBNP (N-terminal pro-Brain Natriuretic Peptide), a biomarker of intracardiac pressures and predictor of heart failure events. The goal of this pilot study is to prospectively investigate changes in blood pressure after stent placement in the aorto-iliac region.

Inclusion: Age ≥18 years; Singed informed consent; Chronic occlusion in the infrarenal aorta and/or one or both common iliac arteries; Total lesion length of ≥30mm; Clinical indication for treatment of the pathology (Chronic limb threatening ischemia or disabling intermittent claudication not responding to supervised exercise training).

Exclusion: Acute occlusion of the target area (Acute Leriche Syndrome); Embolic disease; Patient is unable to understand the study requirements and/ or is unwilling to adhere to the follow-up; Juxtarenal pathology (<2cm below the lowest renal artery).

ClinicalTrials.gov NCT07070583